How to buy Constellation Pharmaceuticals stock

Constellation Pharmaceuticals Inc is a biotechnology business based in the US. Constellation Pharmaceuticals shares (CNST) are listed on the NASDAQ and all prices are listed in US Dollars. Constellation Pharmaceuticals employs 154 staff and has a market cap (total outstanding shares value) of 0.00.

Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Constellation Pharmaceuticals stock price (NASDAQ: CNST)

Use our graph to track the performance of CNST stocks over time.

Constellation Pharmaceuticals shares at a glance

• Key figures

Information last updated 2021-09-12.

Latest market close	$19.81
52-week range	$0.00 - $0.00
50-day moving average more info button	$33.82
200-day moving average more info button	$28.33
Wall St. target price	$40.71
PE ratio more info button	N/A
Dividend yield more info button	N/A (0%)
Earnings per share (TTM) more info button	$-3.04

Buy Constellation Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Constellation Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Constellation Pharmaceuticals price performance over time

Historical closes compared with the close of $19.81 from 2021-05-28

1 week (2022-09-22)	N/A
1 month (2022-08-30)	N/A
3 months (2022-06-29)	N/A
6 months (2022-03-30)	N/A

1 year (2021-09-29)	N/A
2 years (2020-10-02)	-8.96%
3 years (2019-10-03)	141.88%
5 years (2017-09-29)	N/A

Constellation Pharmaceuticals financials

Gross profit TTM	$0
Return on assets TTM	-22.41%
Return on equity TTM	-40.7%
Profit margin	0%
Book value	$7.88
Market capitalisation more info button	$1.6 billion

TTM: trailing 12 months

Constellation Pharmaceuticals share dividends

We're not expecting Constellation Pharmaceuticals to pay a dividend over the next 12 months.

Constellation Pharmaceuticals share price volatility

Over the last 12 months, Constellation Pharmaceuticals's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Constellation Pharmaceuticals's is 2.5804. This would suggest that Constellation Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Constellation Pharmaceuticals overview

Constellation Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, discovers and develops therapeutics to address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. The company's lead product candidates include Pelabresib that is in Phase 3 clinical trials for the treatment of patients with myelofibrosis in combination with ruxolitinib. It is also developing CPI-0209 that is in Phase 1 dose escalation portion of a Phase 1/2 clinical trial to treat solid tumors; and CPI-482, which is in preclinical stage for cancer patients. The company was formerly known as Epigenetix, Inc. and changed its name to Constellation Pharmaceuticals, Inc. in March 2008.

Frequently asked questions

What percentage of Constellation Pharmaceuticals is owned by insiders or institutions?
Currently 1.528% of Constellation Pharmaceuticals shares are held by insiders and 109.699% by institutions. How many people work for Constellation Pharmaceuticals?
Latest data suggests 154 work at Constellation Pharmaceuticals. When does the fiscal year end for Constellation Pharmaceuticals?
Constellation Pharmaceuticals's fiscal year ends in December. Where is Constellation Pharmaceuticals based?
Constellation Pharmaceuticals's address is: 215 First Street, Cambridge, MA, United States, 02142 What is Constellation Pharmaceuticals's ISIN number?
Constellation Pharmaceuticals's international securities identification number is: US2103731061 What is Constellation Pharmaceuticals's CUSIP number?
Constellation Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 210373106